Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NSC-109,724

Known as: NSC 109,724, NSC109724, NSC109,724 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Ifosfamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1976
1976
Studies on the metabolism of isopnosphamide (NSC-109724) in man.
A method is described for the quantitative determination of cyclophosphamide, isophosphamide, and trophosphamide and their stable… Expand
Is this relevant?
1976
1976
Studies on the human pharmacokinetics of isophosphamide (NSC-109724).
The pharmacokinetics of isophosphamide (IP) in man has been studied using 14C-labeled drug and differential extraction of… Expand
Is this relevant?
1976
1976
Studies on the clinical pharmacology and toxicology of isophosphamide (NSC-109724).
 
Is this relevant?
1975
1975
Phase I clinical trial of isophosphamide (NSC-109724).
An initial clinical phase I trial of isophosphamide has been carried out at dose levels of 200-10,000 mg/m2 of body surface area… Expand
Is this relevant?
1975
1975
Inhibition of antilymphoma allograft response in normal and lethally irradiated mice by cyclophosphamide (NSC-26271) and isophosphamide (NSC-109724).
Cyclophosphamide and isophosphamide (an analog) were tested for their effect on the antilymphoma allograft reaction in normal and… Expand
Is this relevant?
1974
1974
Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer.
 
Is this relevant?
1974
1974
Renal dysfunction after treatment with isophosphamide (NSC-109724).
 
Is this relevant?
1973
1973
Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.
 
Is this relevant?
1972
1972
In vitro activation of isophosphamide (NSC-109724), a new oxazaphosphorine, by rat liver microsomes.
 
Is this relevant?
1972
1972
Comparison of the cardiovascular actions of NSC-109,724 (ifosfamide) and cyclophosphamide.
Abstract The iv administration of the alkylating agents NSC-109,724 (ifosfamide) or cyclophosphamide (75, 150 or 300 mg/kg) in… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE